Overview / Abstract: |
Target Audience This activity is intended for oncologists and pathologists who care for/manage patients with NSCLC and thyroid cancer. Program Overview New genetic markers and targeted therapies are driving a rapidly evolving landscape in cancer care. Are you ready to test for these markers and select appropriate treatment options? Learn about RET alterations in lung cancer and thyroid cancer from experts Dr. Justin Gainor and Dr. Marcia Brose as they present recent evidence and guideline recommendations. Hear patient cases and excerpts from their live discussions. Join your colleagues in this new frontier of personalized medicine, and find out why they say, “Right now, I’m building practice habits. This activity helped set a foundation for becoming an attending in a few months.” Learning Objectives Upon completion of this activity, participants should be able to: Introduce improved models for early and effective biomarker testing |
Expiration |
Jan 28, 2023 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
0.75 AMA PRA Category 1 Credit™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty FACULTY_NAME FACULTY_NAME |
Activity Specialities / Related Topics |
Endocrinology, Oncology / Cancer / Radiation Therapy |
Sponsors / Supporters / Grant Providers |
Lilly and Genentech, Inc. |
Keywords / Search Terms |
Relias LLC Relias LLC., FreeCME., Thyroid Cancer Free CE CME |